Evaluation of the Safety, Tolerability and PK Characteristics of GV1001 in Healthy Subjects

Clinical trial NCT06625710 · COMPLETED

Trial details

NCT number: NCT06625710
Sponsor: GemVax & Kael
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Neuro-Degenerative Disease

Start date: 2024-10-08
Primary completion: 2025-08-25
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.